0000899243-22-029030.txt : 20220817 0000899243-22-029030.hdr.sgml : 20220817 20220817173929 ACCESSION NUMBER: 0000899243-22-029030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220815 FILED AS OF DATE: 20220817 DATE AS OF CHANGE: 20220817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arbuckle Stuart A CENTRAL INDEX KEY: 0001557290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 221175522 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-15 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001557290 Arbuckle Stuart A C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, COO Common Stock 2022-08-15 4 M 0 6571 155.57 A 67451 D Common Stock 2022-08-15 4 S 0 1254 300.30 D 66197 D Common Stock 2022-08-15 4 S 0 4242 301.61 D 61955 D Common Stock 2022-08-15 4 S 0 400 302.55 D 61555 D Common Stock 2022-08-15 4 S 0 2339 303.78 D 59216 D Common Stock 2022-08-15 4 S 0 6990 304.67 D 52226 D Common Stock 2022-08-15 4 S 0 6948 305.38 D 45278 D Common Stock 140 I 401(k) Stock Option (Right to Buy) 155.57 2022-08-15 4 M 0 6571 0.00 D 2028-02-05 Common Stock 6571 0 D Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $300.30 (range $300.00 to $300.73). Open market sales reported on this line occurred at a weighted average price of $301.61 (range $301.09 to $302.01). Open market sales reported on this line occurred at a weighted average price of $302.55 (range $302.13 to $302.90). Open market sales reported on this line occurred at a weighted average price of $303.78 (range $303.13 to $304.09). Open market sales reported on this line occurred at a weighted average price of $304.67 (range $304.13 to $305.12). Open market sales reported on this line occurred at a weighted average price of $305.38 (range $305.13 to $305.83). Fully vested. /s/ Joy Liu, Attorney-in-Fact 2022-08-17